替洛利生
替洛利生是一种治疗发作性睡病成人白天嗜睡的药物,[2]它是一种组胺3(H3)受体拮抗剂/反激动剂,[2]是同类药物中第一种上市的药物。[3]它可增强大脑中组胺能神经元的活动,从而提高人的清醒度;[4]其副作用包括睡眠困难、恶心、焦虑等。[5]
![]() | |
| 臨床資料 | |
|---|---|
| 商品名 | Wakix, Ozawade |
| 其他名稱 | Tiprolisant; Ciproxidine; BF2.649 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a619055 |
| 核准狀況 |
|
| 给药途径 | By mouth |
| 藥物類別 | Histamine H3 receptor inverse agonists |
| ATC碼 | |
| 法律規範狀態 | |
| 法律規範 | |
| 识别 | |
| |
| CAS号 | 362665-56-3 903576-44-3 |
| PubChem CID | |
| DrugBank |
|
| ChemSpider | |
| UNII |
|
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| 化学 | |
| 化学式 | C17H26ClNO |
| 摩尔质量 | 295.85 g·mol−1 |
| 3D模型(JSmol) | |
| |
| |
参考文献
- . Health Canada. 23 October 2014 [29 May 2022]. (原始内容存档于2022-12-22).
- . DailyMed. 6 November 2019 [18 August 2020]. (原始内容存档于2020-08-11).
- . Pharmacy Times. [18 August 2020]. (原始内容存档于2020-08-12).
- Syed YY. . Drugs. 20 July 2016, 76 (13): 1313–1318. PMID 27438291. S2CID 42684839. doi:10.1007/s40265-016-0620-1.
- . U.S. Food and Drug Administration (FDA). 14 August 2019 [18 March 2020]. (原始内容存档于2020-12-22).
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
